Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 1;139(5):548-556.
doi: 10.1001/jamaophthalmol.2021.0320.

Association of Retinal Changes With Alzheimer Disease Neuroimaging Biomarkers in Cognitively Normal Individuals

Affiliations

Association of Retinal Changes With Alzheimer Disease Neuroimaging Biomarkers in Cognitively Normal Individuals

Min Soo Byun et al. JAMA Ophthalmol. .

Abstract

Importance: Retinal biomarkers reflecting in vivo brain Alzheimer disease (AD) pathologic abnormalities could be a useful tool for screening cognitively normal (CN) individuals at the preclinical stage of AD.

Objectives: To investigate the association of both functional and structural alterations of the retina with in vivo AD pathologic abnormalities in CN older adults and model a screening tool for detection of preclinical AD.

Design, setting, and participants: This cross-sectional study included a total of 49 CN individuals, and all assessment was done at the Seoul National University Hospital, Seoul, South Korea. All participants underwent complete ophthalmic examination, including swept-source optical coherence tomography (SS-OCT) and multifocal electroretinogram as well as amyloid-β (Aβ) positron emission tomography and magnetic resonance imaging. Data were collected from January 1, 2016, through October 31, 2017, and analyzed from February 1, 2018, through June 30, 2020.

Main outcomes and measures: For structural parameters of the retina, the thickness of the macula and layer-specific thicknesses, including peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer measured by SS-OCT, were used for analysis. For functional parameters of the retina, implicit time and amplitude of rings 1 to 6 measured by multifocal electroretinogram were used.

Results: Of the 49 participants, 25 were women (51.0%); mean (SD) age was 70.6 (9.4) years. Compared with 33 CN individuals without Aβ deposition (Aβ-CN), the 16 participants with Aβ (Aβ+CN) showed reduced inner nasal macular thickness (mean [SD], 308.9 [18.4] vs 286.1 [22.5] μm; P = .007) and retinal nerve fiber layer thickness, particularly in the inferior quadrant (133.8 [17.9] vs 103.8 [43.5] μm; P = .003). In addition, the Aβ+CN group showed prolonged implicit time compared with the Aβ-CN group, particularly in ring 5 (41.3 [4.0] vs 38.2 [1.3] milliseconds; P = .002). AD-related neurodegeneration was correlated with the thickness of the ganglion cell-inner plexiform layer only (r = 0.41, P = .005). The model to differentiate the Aβ+CN vs Aβ-CN groups derived from the results showed 90% accuracy.

Conclusions and relevance: The findings of this study showing both functional as well as structural changes of retina measured by multifocal electroretinogram and SS-OCT in preclinical AD suggest the potential use of retinal biomarkers as a tool for early detection of in vivo AD pathologic abnormalities in CN older adults.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Recruitment of Participants
Abbreviations: Aβ, amyloid-β; CN, cognitively normal.
Figure 2.
Figure 2.. Representative Images of Carbon 11–Labeled Pittsburgh Compound B Positron Emission Tomography ([11C] PiB-PET) and Magnetic Resonance Imaging (MRI)
A, A cognitively normal (CN) older adult in the group with no amyloid-β (Aβ) deposition with a typical negative amyloid scan of [11C] PiB-PET (left), showing only nonspecific uptake in the white matter (WM) tract (arrowhead) and no PiB uptake in cerebral gray matter (GM), as well as no significant bilateral temporal atrophy in brain MRI (right). B, A CN older adult in the group with Aβ deposition with a typical positive amyloid scan of [11C] PiB-PET, showing PiB retention in cerebral GM (left, arrowheads) and bilateral temporal atrophy in MRI (right, yellow circle).
Figure 3.
Figure 3.. Comparison of Structural and Functional Parameters of Retina Measured by Swept-Source Optical Coherence Tomography and Multifocal Electroretinography Between Cognitively Normal (CN) Individuals With and Without Amyloid-β Deposition
A, Macular thickness of the area in the inner ring of macula. B, Subregional comparison of the thickness of the retinal nerve fiber layer (RNFL) quadrant. C, Implicit time from ring 1 to 6. Dot and error bar indicates adjusted mean and SEM obtained from analysis of covariance after adjusting covariates (age, sex, APOE4, and best-corrected visual acuity).
Figure 4.
Figure 4.. Association of Retinal Structural Parameters by Swept-Source Optical Coherence Tomography With Alzheimer Disease (AD) Signature Cortical Thickness (AD-CT)
The mean ganglion cell-inner plexiform layer (GCIPL) thickness was associated with AD-CT (A), but the mean retinal nerve fiber layer (RNFL) thickness was not associated with AD-CT (B).

Comment in

References

    1. Jack CR Jr, Knopman DS, Jagust WJ, et al. . Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119-128. doi:10.1016/S1474-4422(09)70299-6 - DOI - PMC - PubMed
    1. Sperling RA, Aisen PS, Beckett LA, et al. . Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280-292. doi:10.1016/j.jalz.2011.03.003 - DOI - PMC - PubMed
    1. Parnetti L, Chipi E, Salvadori N, D’Andrea K, Eusebi P. Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis. Alzheimers Res Ther. 2019;11(1):7. doi:10.1186/s13195-018-0459-7 - DOI - PMC - PubMed
    1. Ikram MK, Cheung CY, Wong TY, Chen CP. Retinal pathology as biomarker for cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2012;83(9):917-922. doi:10.1136/jnnp-2011-301628 - DOI - PubMed
    1. London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9(1):44-53. doi:10.1038/nrneurol.2012.227 - DOI - PubMed

Publication types